NewslettersCell Therapy NewsProstate Cell Newsγδ-Enriched CAR-T Cell Therapy for Bone Metastatic Castrate-Resistant Prostate CancerBy Bob - May 5, 20230162Scientists reported a combinatorial strategy to treat bone metastatic castrate-resistant prostate cancer using γδ-enriched chimeric antigen receptor (CAR) T cells and zoledronate.[Science Advances]Full ArticlePress Release